Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby

A respiratory syndrome and inactivated vaccine technology, applied in the field of virus strains, porcine reproductive and respiratory syndrome virus strains, inactivated vaccines and their preparation, can solve problems such as inability to provide effective protection and achieve good emulsification effect , Small side effects, easy injection effect

Active Publication Date: 2009-03-04
华威特(江苏)生物制药有限公司
View PDF0 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, foreign studies have shown that recent outbreaks of atypical and acute PRRS caused by emerging PRRSV strains in the United States and other North American countries cannot provide effective protection with current vaccines

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby
  • Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby
  • Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1 Isolation and acquisition of PRRSV TJ strain

[0023] A strain of virus was isolated from the diseased material collected from a dead pig in a pig farm with high fever in Tianjin. After blind passage of Marc-145 cells for 2 generations, it showed characteristic PRRS cell lesions. After RT-PCR detection, both samples amplified The target fragments of 433bp and 468bp were found, which proved that the isolate was American type (see figure 1 ). Returning the isolated virus cell culture to animals produces PRRS-specific clinical symptoms, high fever, skin flushing, loss of appetite, depression, hind limb lameness or even paralysis, mild dyspnea, and the incidence rate is 100%. The virus was isolated again from the test animal, and its GP5 and Nsp2 genes were amplified and sequenced. The results showed that the strain was a mutated PRRSV, and the strain was named PRRSV TJ strain. The sequence is shown in SEQ ID NO: 1, and the strain is submitted for deposit, and i...

Embodiment 2

[0024] Example 2 Purification and isolation of virus

[0025] The PRRSV TJ strain was diluted 10 times serially, and the dilution range was 10 -2 -10 -6 , after dilution, inoculate a 6-well cell culture plate covered with a single layer of Marc-145 cells, 1ml / well, absorb for 1h, discard the virus solution, wash twice with serum-free MEM, add 2× nutrient solution and sterilized agar solution Mixed solution, 3ml / well, after cooling at room temperature, place at 37°C 5% CO 2 Cultivate in an incubator for 3-4 days, observe the plaques, and pick a single plaque in a well with fewer plaques for passage.

Embodiment 3

[0026] Example 3 PRRSV inactivation and inactivation effect test

[0027] (1), PRRSV inactivation

[0028] (1) Cell culture: culture Marc-145 cells in spinner bottles to make the cell density reach 5-10×10 7 / ml;

[0029](2) virus inoculation: be 0.01-0.5 PRRSV TJ strain of the present invention is inoculated in the Marc-145 cell cultured of step (1) with infectious dose (MOI), cultivate 3-5 days, when cytopathic changes reaches 80% Harvest the virus fluid;

[0030] (3) Add BEI to the virus liquid harvested in step (2), the final concentrations are 1mM, 2mM and 3mM respectively, make it fully mixed, and then place it at 37°C for inactivation, before adding BEI (0h) and after adding BEI Samples were collected at 30min, 1h, 2h, 4h, 8h, 12h, 24h, and 28h (10ml / time), and the collected samples were used for virus titer determination, and the inactivation kinetic curve was drawn. Determine the final concentration of BEI and the optimal inactivation time, see the kinetic curve o...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a separated porcine reproductive and respiratory syndrome virus JJ strain with the microorganism collection number of CGMCC NO.2129, an inactivated vaccine prepared by the virus strain and a preparation method thereof. The porcine reproductive and respiratory syndrome virus inactivated vaccine has good immune protection effectiveness, and can effectively prevent porcine reproduction and respiratory syndrome.

Description

technical field [0001] The invention relates to a virus strain, in particular to a porcine reproductive and respiratory syndrome virus strain. The invention also relates to an inactivated vaccine prepared from the porcine reproductive and respiratory syndrome virus strain and a preparation method thereof, belonging to the field of animal vaccines. Background technique [0002] Porcine Reproductive and Respiratory Syndrome (Porcine Reproductive and Respiratory Syndrome, PRRS) is a new infectious disease caused by PRRSV (Porcine Reproductive and Respiratory Syndrome Virus). Mortality is the main feature. The disease first broke out in North America in 1987, and spread rapidly around the world, causing serious economic losses to the world's pig industry. In China, the prevalence and distribution of PRRS are becoming more and more widespread, and the harm is becoming more and more serious. Especially in 2006, a disease known as "unknown high fever" broke out in some pig farms...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N7/00C12N7/04C12N15/33A61K39/12A61P31/14
Inventor 冷雪温永俊齐巧玲谭斌武华
Owner 华威特(江苏)生物制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap